Samil Pharm (000520) — Capital Reinvestment Ratio
Samil Pharm (000520) has a Capital Reinvestment Ratio of 1.33x as of June 2025, meaning it reinvests 1% of its operating cash flow (₩2.44 Billion) in capital expenditures (₩3.26 Billion). Check 000520 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Samil Pharm Capital Reinvestment Ratio (2012–2024)
This chart tracks Samil Pharm's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see 000520 cash flow conversion.
Annual Capital Reinvestment Ratio for Samil Pharm (2012–2024)
Year-by-year Capital Reinvestment Ratio for Samil Pharm from 2012 to 2024. See 000520 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 2.17x | ₩2.59 Billion | ₩5.61 Billion | ▲ +4.3% |
| 2023 | 2.08x | ₩11.75 Billion | ₩24.39 Billion | ▼ -82.2% |
| 2022 | 11.67x | ₩4.15 Billion | ₩48.48 Billion | ▼ -49.6% |
| 2021 | 23.17x | ₩1.42 Billion | ₩32.83 Billion | ▲ +958.4% |
| 2020 | 2.19x | ₩7.77 Billion | ₩17.02 Billion | ▲ +66.9% |
| 2019 | 1.31x | ₩10.59 Billion | ₩13.89 Billion | ▼ -86.3% |
| 2017 | 9.58x | ₩3.79 Billion | ₩36.33 Billion | ▲ +1112.5% |
| 2016 | 0.79x | ₩5.63 Billion | ₩4.45 Billion | ▼ -2.1% |
| 2015 | 0.81x | ₩2.92 Billion | ₩2.36 Billion | ▲ +112.4% |
| 2012 | 0.38x | ₩5.02 Billion | ₩1.91 Billion | — |